Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed accessible beauty brand with $1B+ revenue offering vegan makeup at $5-20 drugstore prices; TikTok-viral "dupe" strategy competing with NYX and prestige brands for Gen Z consumers.
e.l.f. Cosmetics is an accessible luxury beauty brand producing makeup, skincare, and beauty tools at drugstore price points — offering products like primers, foundations, eyeshadow palettes, lip glosses, and SPF moisturizers that are entirely vegan and cruelty-free, at price points of $5-20 that undercut premium brands by 80-90%. Founded in 2004 in Oakland, California by Joseph Shamah and Scott Vincent Borba, e.l.f. is publicly traded on NYSE (NYSE: ELF) and has grown to approximately $1 billion in annual net sales, becoming one of the fastest-growing beauty brands in the US.\n\ne.l.f.'s product development strategy involves "duping" high-end makeup products at a fraction of the cost — the e.l.f. Putty Primer ($10) is a frequent comparison to Tatcha Silk Canvas Primer ($52), the Halo Glow Liquid Filter ($14) competes with Charlotte Tilbury Hollywood Flawless Filter ($46). This dupe culture has made e.l.f. a social media phenomenon, particularly on TikTok where product comparisons and "get the look" content drives viral awareness. The brand's 100% vegan and cruelty-free credentials resonate strongly with Gen Z consumers.\n\nIn 2025, e.l.f. is one of the few beauty brands that has consistently taken market share from both mass and prestige competitors — its "eyes, lips, face" brand promise and the value proposition of luxury quality at drugstore prices has driven growth even as overall beauty market growth moderates. e.l.f. competes with NYX (L'Oréal), Wet n Wild, and Maybelline in accessible makeup, and with Rare Beauty, Too Faced, and Urban Decay in the prestige-adjacent segment. The 2025 strategy focuses on skincare expansion (a higher-growth category with better margins than color cosmetics), international expansion (UK, Canada, and European markets where brand awareness is growing), and maintaining the digital-native marketing approach that has built its Gen Z audience.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.